| |
|
|
|
|
|
|
|||
|
Blood, 15 February 2008, Vol. 111, No. 4, pp. 1894-1902. Prepublished online as a Blood First Edition Paper on November 29, 2007; DOI 10.1182/blood-2007-02-071746.
Submitted February 1, 2007
Division of Experiemental Hematology, Cincinnati Children's Hospital Medical Center, Department of Medicine, University of Cincinnati, Cincinnati, OH, United States * Corresponding author; email: hartmut.geiger{at}cchmc.org.
The retinoblastoma tumor suppressor protein (RB) plays important roles in the control of the cell division cycle. It is estimated that RB is dysfunctional/inactivated in up to 40% of human leukemias. The consequences of loss of RB on hematopoietic stem and progenitor cell (HSPC) function in vivo are incompletely understood. Here we report that mice genetically deficient in Rb in all hematopoietic cells (Vav-Cre Rb KO animals) showed altered contribution of distinct hematopoietic cell lineages to peripheral blood, bone marrow and spleen, significantly increased extramedullary hematopoiesis in the spleen and a 2-fold increase in the frequency of hematopoietic progenitor cells in peripheral blood. Upon competitive transplantation, HSPCs from Vav-Cre Rb KO mice contributed with an at least 4 to 6-fold less efficiency to hematopoiesis compared to control cells. HSPCs deficient in Rb presented with impaired cell-cycle exit upon stress-induced proliferation, which correlated with impaired function. In summary, Rb is critical for hematopoietic stem and progenitor cell function, localization, and differentiation.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||